Stockscreener 앱 받기
40.32
1.25%
-0.51
시간 외 거래:
40.32
전일 마감가:
$40.83
열려 있는:
$40.45
하루 거래량:
752.87K
Relative Volume:
1.57
시가총액:
$1.25B
수익:
$1.32B
순이익/손실:
$110.20M
주가수익비율:
11.38
EPS:
3.5417
순현금흐름:
$148.24M
1주 성능:
-0.62%
1개월 성능:
-4.09%
6개월 성능:
-24.71%
1년 성능:
-44.42%
1일 변동 폭
$39.76
$40.81
1주일 범위
$38.32
$41.16
52주 변동 폭
$38.32
$74.70
Conmed Corp Stock (CNMD) Company Profile
명칭
Conmed Corp
전화
727-214-2974
주소
11311 CONCEPT BOULEVARD, LARGO, NY
CNMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
40.32 | 1.26B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
128.47 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.19 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.31 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.57 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.38 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-12 | 다운그레이드 | Needham | Buy → Hold |
| 2025-04-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-02-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-01 | 재확인 | Needham | Buy |
| 2023-05-22 | 개시 | CL King | Buy |
| 2023-03-27 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-10-06 | 업그레이드 | Needham | Hold → Buy |
| 2021-07-15 | 개시 | UBS | Buy |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2019-11-26 | 다운그레이드 | Needham | Buy → Hold |
| 2019-11-12 | 개시 | JP Morgan | Overweight |
| 2019-10-31 | 재확인 | Needham | Buy |
| 2019-10-04 | 재확인 | Needham | Buy |
| 2019-08-22 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | 개시 | Stifel | Buy |
| 2019-04-16 | 재확인 | Needham | Buy |
| 2019-01-23 | 재확인 | Needham | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-08-07 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-04-26 | 재확인 | Needham | Buy |
| 2018-02-01 | 재확인 | Needham | Buy |
| 2017-07-27 | 재확인 | Needham | Buy |
| 2017-04-27 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | 재확인 | Needham | Buy |
| 2016-11-18 | 재확인 | Needham | Buy |
| 2016-07-28 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | 재확인 | Needham | Buy |
| 2015-10-22 | 재확인 | Northland Capital | Market Perform |
모두보기
Conmed Corp 주식(CNMD)의 최신 뉴스
Here's Why Conmed (CNMD) is a Strong Growth Stock - Yahoo Finance
CONMED (NYSE:CNMD) Price Target Lowered to $52.00 at Bank of America - Defense World
CONMED (NYSE:CNMD) Shares Little Changed After Operations Update - Kalkine Media
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio - Yahoo Finance
Conmed to exit gastroenterology business - Yahoo Finance
Is CONMED (CNMD) Trading Niche Biliary Devices For A Higher-Margin Endoscopy Future? - Yahoo Finance
Looking at the Narrative for CONMED After Analyst Model Tweaks and Capital Moves - Yahoo Finance
How Conmed Corp.Ordinary Shares (CNMD) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Here's why you should add CONMED stock to your portfolio now - MSN
CONMED (NYSE:CNMD) Hits New 52-Week LowWhat's Next? - MarketBeat
CONMED (CNMD) Passes Through 2% Yield Mark - Nasdaq
CONMED to Exit Gastroenterology Market - Medical Product Outsourcing
CONMED to exit gastroenterology product lines as part of portfolio shift - Medical Economics
Why CONMED (CNMD) Shares Are Plunging Today - Finviz
Conmed stock hits 52-week low at 40.0 USD - Investing.com
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report? - Yahoo Finance
Why Is Conmed Stock Falling Friday?Conmed (NYSE:CNMD) - Benzinga
Conmed to exit gastroenterology product lines, transfer Gore Viabil rights to Olympus - MassDevice
Conmed to conclude distribution agreement with W. L. Gore & Associates - TipRanks
Conmed to Exit Gastroenterology Product Lines, End Distribution Deal With Gore - marketscreener.com
Conmed to exit gastroenterology business, ends Gore distribution deal - Investing.com
Conmed to exit gastroenterology business, ends Gore distribution deal By Investing.com - Investing.com Canada
Conmed Exits Gastroenterology Products to Focus on Core Markets - TipRanks
CONMED Corp Announces Strategic Exit from Gastroenterology Product Lines - TradingView — Track All Markets
Conmed Corp announces exit from gastroenterology product lines - marketscreener.com
Conmed Announces Exclusive U.S. and Canadian Distribution Rights for the Gore® Viabil® Biliary Stent - marketscreener.com
Zacks.com featured highlights include Plains GP, Edison International, TD SYNNEX, CONMED and PG&E - sharewise.com
Here's Why You Should Add CONMED Stock to Your Portfolio Now - sharewise.com
Will CONMED Corporation stock keep outperforming rivals2025 Short Interest & Verified Technical Signals - Newser
Fisher Asset Management LLC Has $18.92 Million Holdings in CONMED Corporation $CNMD - Defense World
Why institutional investors increase stakes in CONMED Corporation stockWeekly Market Report & Daily Technical Stock Forecast Reports - Newser
Is CONMED Corporation stock overvalued by current metricsJuly 2025 Setups & Expert Verified Stock Movement Alerts - Newser
Can CONMED Corporation (EC8) stock sustain double digit ROEGlobal Markets & Technical Buy Zone Confirmations - Newser
Are Investors Undervaluing CONMED (CNMD) Right Now? - Yahoo Finance
What downside risks could hit CONMED Corporation (EC8) stock2025 Historical Comparison & Entry Point Strategy Guides - Newser
Evaluating CONMED (CNMD) Valuation After Recent Share Price Decline - Yahoo Finance
Geode Capital Management LLC Grows Stock Position in CONMED Corporation $CNMD - MarketBeat
Why Conmed (CNMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Champlain Investment Partners LLC Lowers Position in CONMED Corporation $CNMD - MarketBeat
Insider Selling: CONMED (NYSE:CNMD) Insider Sells $10,590.97 in Stock - MarketBeat
Conmed’s CIO Glaze sells $10.5k in shares By Investing.com - Investing.com Canada
Conmed’s CIO Glaze sells $10.5k in shares - Investing.com
CONMED Corp CIO Richard Glaze Sells Shares - TradingView
Officer Glaze Sells 257 ($10.6K) Of CONMED Corp [CNMD] - TradingView
[Form 4] CONMED Corp Insider Trading Activity - Stock Titan
Why Conmed (CNMD) is a Top Value Stock for the Long-Term - Yahoo Finance
Dynamic Technology Lab Private Ltd Acquires New Stake in CONMED Corporation $CNMD - MarketBeat
CONMED, Select Medical, BrightSpring Health Services, Privia Health, and RadNet Shares Are Soaring, What You Need To Know - Barchart.com
Officer Glaze Acquires 257 Of CONMED Corp [CNMD] - TradingView
Officer Glaze Files To Sell 257 Of CONMED Corp [CNMD] - TradingView
CONMED (NYSE:CNMD) Reaches New 52-Week LowShould You Sell? - MarketBeat
Conmed Corp (CNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.42%
0.91%
자본화:
|
볼륨(24시간):